Additionally, Syk is a confirmed key molecular target involved in NETosis within AKI, and Syk inhibitors have demonstrated NETosis-blocking activity (89, 90), suggesting that Syk inhibitors could be useful agents for preventing renal injury in patients and warranting future research attention. This evidence concerns the gene SYK and acute kidney injury.